- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Axxess Pharma Approved to Sell Omega-3 Fish Oil Supplement in Canada
Axxess Pharma Inc. (OTCMKTS:AXXE), through its wholly owned subsidiary, AllStar Health Brands Inc., has now received approval from Health Canada to sell their high potency Omega-3 fish oil supplement throughout Canada. The Company will be selling this under the globally recognized TapouT name.
Axxess Pharma Inc. (OTCMKTS:AXXE), through its wholly owned subsidiary, AllStar Health Brands Inc., has now received approval from Health Canada to sell their high potency Omega-3 fish oil supplement throughout Canada. The Company will be selling this under the globally recognized TapouT name.
As quoted in the press release:
The Omega-3 fish oil will be sold under the globally recognized TapouT name with all revenues flowing directly into Axxess Pharma, Inc. The company anticipates generating significant residual sales from the $1 billion Canadian Omega-3 oil market.
Click here to read the Axxess Pharma Inc. (OTCMKTS:AXXE) press release
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â